An independent legal panel rejects allegations in shareholder lawsuits that Medtronic ran a scheme to promote off-label use of its controversial Infuse bone growth product.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hETwm4
Cap comentari:
Publica un comentari a l'entrada